Extensive superior limbic keratoconjunctivitis in Graves' disease: case report and mini-review of the literature.
Details
Serval ID
serval:BIB_4A37FA8FA666
Type
Article: article from journal or magazin.
Publication sub-type
Case report (case report): feedback on an observation with a short commentary.
Collection
Publications
Institution
Title
Extensive superior limbic keratoconjunctivitis in Graves' disease: case report and mini-review of the literature.
Journal
Clinical Ophthalmology
ISSN
1177-5467 (Print)
ISSN-L
1177-5467
Publication state
Published
Issued date
03/2015
Peer-reviewed
Oui
Volume
9
Pages
467-468
Language
english
Notes
Publication types: Journal ArticlePublication Status: epublish
Abstract
BACKGROUND: Superior limbic keratoconjunctivitis (SLK) is characterized as an inflammation of the superior bulbar conjunctiva with predominant involvement of the superior limbus and adjacent epithelial keratitis.
METHODS: A 51-year-old woman, with a history of medically controlled Graves' disease was seen with an extensive SLK involving 5 mm of the superior cornea.
RESULTS: Total remission was observed with topical steroids (DXM). Recurrence was observed 1 week after steroid discontinuation, and steroidal treatment was reintroduced with tapering over 1 month. Total remission was then observed for 1 year.
CONCLUSION: Extensive keratitis and vascular pannus in SLK is rarely reported. This form could be treated with topical steroids. Tapering treatment remains essential for long-term success.
METHODS: A 51-year-old woman, with a history of medically controlled Graves' disease was seen with an extensive SLK involving 5 mm of the superior cornea.
RESULTS: Total remission was observed with topical steroids (DXM). Recurrence was observed 1 week after steroid discontinuation, and steroidal treatment was reintroduced with tapering over 1 month. Total remission was then observed for 1 year.
CONCLUSION: Extensive keratitis and vascular pannus in SLK is rarely reported. This form could be treated with topical steroids. Tapering treatment remains essential for long-term success.
Pubmed
Web of science
Open Access
Yes
Create date
02/02/2016 18:44
Last modification date
20/08/2019 14:57
Usage data
